Fast Money Traders Answer Viewer Questions on Stocks and Markets

Pharmaceutical Stock Analysis

• 💡 David inquired about pharmaceutical stocks like Merck and Pfizer, noting they were once safe havens but are now primarily dividend-producing.
• 🎯 Tim highlighted that Merck was a strong performer through 2023 but has faced challenges due to competitive pressures and pipeline exclusivity loss.
• 🔑 Pfizer's situation is understood, and J&J is suggested as an alternative, offering diversification across medical, medtech, consumer, and pharma sectors, including oncology.
• ⚠️ It is advised not to sell these stocks at the current time.

Utility Stocks and Interest Rates

• ❓ Diana asked for recommendations on utility company stocks with a one-year timeline, considering the current interest rate environment and electricity demand.
• 📈 Carter suggested NextEra, noting it offers a higher yield than the sector average, along with a growth component.

Netflix Position Protection

• 💬 Gus, holding a substantial Netflix position that has appreciated significantly, sought advice on protecting his gains, especially with discussions around tariffs on foreign films.
• 💰 Bonner recommended a collar strategy, involving buying a downside put (e.g., 90% strike) and selling an upside call (e.g., 110% strike) to fund the put, or adjusting the call strike and rolling out the maturity if uncomfortable selling.

Upcoming Fast Money Live Event

• 🗓️ A reminder about the upcoming 'Fast Money' Live event on June 5th at the NASDAQ, with limited spots available.
• 🎟️ Viewers are encouraged to scan a QR code or visit cnbcevents.com/fastmoney to purchase tickets.